Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.

13
Number of overlapping holdings
44.8%
% of PBE's 29 holdings also in FBT
43.3%
% of FBT's 31 holdings also in PBE
Overlap by Weight
Sector Drift (PBE minus FBT)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
Company | Weight in PBE |
Weight in FBT |
Overlap | |
---|---|---|---|---|
BIOMARIN PHARMACEUTICAL INC | 5.3% | 3.6% | 3.6% | |
UNITED THERAPEUTICS CORP | 5.4% | 3.4% | 3.4% | |
REGENERON PHARMACEUTICALS | 5.1% | 3.3% | 3.3% | |
VERTEX PHARMACEUTICALS INC | 5.4% | 3.2% | 3.2% | |
GILEAD SCIENCES INC | 5.3% | 3.2% | 3.2% |
Position Highlights (Non-Overlapping Exposures)
PBE Overweight Relative to FBT
VERICEL CORPORATION | 3.2% | |
INTRA-CELLULAR THERAPIES INC | 3.1% | |
ARROWHEAD PHARMACEUTICALS, INC. | 3.0% | |
MYRIAD GENETICS INC | 3.0% | |
VERACYTE INC | 3.0% | |
REPLIGEN CORP | 2.9% | |
CATALYST PHARMACEUTICAL PART | 2.8% | |
HALOZYME THERAPEUTICS INC | 2.8% | |
DYNAVAX TECHNOLOGIES CORP | 2.7% | |
OPKO HEALTH INC | 2.6% |
PBE Underweight Relative to FBT
GRIFOLS SA-ADR | -3.9% | |
ULTRAGENYX PHARMACEUTICAL IN | -3.8% | |
IQVIA HOLDINGS INC | -3.7% | |
BIONTECH SE SPONSORED ADR | -3.6% | |
IONIS PHARMACEUTICALS, INC. | -3.5% | |
GENMAB A/S SPONSORED ADR | -3.5% | |
METTLER-TOLEDO INTERNATIONAL | -3.5% | |
CHARLES RIVER LABORATORIES | -3.5% | |
ARGENX SE ADR | -3.4% | |
AGIOS PHARMACEUTICALS INC | -3.4% |